Jul 2026
Exploration of new biomarkers for rheumatoid arthritis based on plasma proteomics and transcriptome integrated with genome-wide Mendelian randomization.
Research on polygenic risk model indicates CAMK2G protein could serve as a promising biomarker and NR1H3 might be a potential candidate for targeting therapy for RA.
Peng Zhang, You-Bang Liang, Xin Li et al.
· Journal of Autoimmunity · 0 citations